Evidence map›Paper›PMID 27282770›Full record

ArticleMolecular neurobiology2017

Effects of BDNF-Transfected BMSCs on Neural Functional Recovery and Synaptophysin Expression in Rats with Cerebral Infarction.

Yongming Zhang, Binghui Qiu, Jinbiao Wang, Yi Yao, Chunlin Wang, Jiachuan Liu

RetractedAbstract readRetracted Publication
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 33 citations in OpenAlex.

  1. Unleashing endogenous regeneration by senolytics.Journal of translational medicine · 2025
    Review
  2. Review
  3. Article
  4. Review
  5. Ras Inhibitor Lonafarnib Rescues Structural and Functional Impairments of Synapses of AβThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yongming ZhangDepartment of Neurosurgery, No. 105 Hospital of PLA, No. 424 Changjiang West Road, Hefei, 230031, Anhui, People's Republic of China. zymhf2966@163.com.
Binghui QiuDepartment of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, People's Republic of China.
Jinbiao WangDepartment of Neurosurgery, No. 105 Hospital of PLA, No. 424 Changjiang West Road, Hefei, 230031, Anhui, People's Republic of China.
Yi YaoDepartment of Neurosurgery, No. 105 Hospital of PLA, No. 424 Changjiang West Road, Hefei, 230031, Anhui, People's Republic of China.
Chunlin WangDepartment of Neurosurgery, No. 105 Hospital of PLA, No. 424 Changjiang West Road, Hefei, 230031, Anhui, People's Republic of China.
Jiachuan LiuDepartment of Neurosurgery, No. 105 Hospital of PLA, No. 424 Changjiang West Road, Hefei, 230031, Anhui, People's Republic of China.
Nanfang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to investigate the effects of brain-derived neurotrophic factor (BDNF)-transfected bone marrow mesenchymal stem cells (BMSCs) on neural functional recovery and synaptophysin expression in rats with cerebral infarction (CI). A total of 120 healthy Sprague Dawley rats were randomly divided into sham group, control group, and model group. Craniotomy was conducted and neurological function defect scoring was used to verify the model. BDNF containing recombinant plasmid was transfected into rat BMSCs, which was verified by flow cytometry and Western Blot. After injection of the transfected BMSCs, neural functional recovery of the CI rats and synaptophysin expression were measured. After the CI rat model was established, magnetic resonance (MR) imaging, 2, 3, 5- triphenyl tetrazolium chloride (TTC) staining, and the neurological function defect scoring determined the success of the model. CD34 (-), CD45 (-), CD29 (+), and CD90 (+) cells detected showed that the obtained BMSCs have high purity. BDNF protein was highly expressed in the BMSCs successfully transfected with the recombinant plasmid. Balance beam walking score, rotating bar walking score, and screen test score were significantly lower, while synaptophysin expression was higher in the BDNF model group than those in the non-BDNF model group and sham group with time extension. BDNF can increase synaptic plasticity and neurogenesis and have a promotional role in neural functional recovery and synaptophysin expression in rats with CI. BDNF-transfected BMSCs may therefore have better treatment efficacy for CI clinically.

Indexed as

Mesenchymal Stem Cell TransplantationRecovery of FunctionTransfectionAnimalsBrain-Derived Neurotrophic FactorCell ShapeCerebral InfarctionDisease Models, AnimalMagnetic Resonance ImagingMesenchymal Stem CellsMicrotubule-Associated ProteinsNerve TissuePlasmidsRats, Sprague-DawleyRNA, MessengerSynaptophysinBrain-Derived Neurotrophic FactorMAP2 protein, ratMicrotubule-Associated ProteinsRNA, MessengerSynaptophysinBone marrow mesenchymal stem cellsBrain-derived neurotrophic factorCerebral infarctionFlow cytometryImmunohistochemistryNeural functional recoverySynaptophysinTransfection

Identifiers

PMID27282770
OpenAlexW2414895022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.